Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Gastrointestinal effects and binding profile of Taisho's 5-HT4 agonist TS-951

March 25, 1999

Positive phase I results reported for Il Yang's proton pump inhibitor

March 23, 1999

Gilead initiates phase III trial of adefovir dipivoxil in treatment of HBV

March 22, 1999

SciClone receives additional Zadaxin marketing approvals in Singapore and Vietnam

March 19, 1999

Benzamides with low nanomolar affinity for 5-HT4 receptors

March 18, 1999

InKine completes enrollment of first pivotal phase III clinical trial of Diacol

March 18, 1999

Structure of Astra's next-generation proton pump inhibitor revealed for the first time

March 16, 1999

Health Canada approves Rebetron for chronic HCV

March 15, 1999

Agents for stimulating upper and lower GI motility in development at Labs. Jacques Logeais

March 9, 1999

Gene therapy with human HGF proves simple, safe and effective in rats with cirrhosis

March 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...